| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.26 | 9e-06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.22 | 9e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0004 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |